Renhe Pharmacy Co.,Ltd (SHE:000650)

Market Cap	8.20B +3.0%
Revenue (ttm)	3.76B -13.9%
Net Income	445.37M +0.6%
EPS	0.32 +1.0%
Shares Out	1.38B
PE Ratio	18.55
Forward PE	n/a
Dividend	0.15 (2.57%)
Ex-Dividend Date	Jun 17, 2025

Volume	19,402,184
Average Volume	38,319,753
Open	6.03
Previous Close	5.84
Day's Range	5.86 - 6.03
52-Week Range	5.10 - 7.02
Beta	0.56
RSI	43.10
Earnings Date	Apr 24, 2026

About Renhe Pharmacy Co.,Ltd

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is based in Nanchang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 5,394
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000650

Financial Performance

In 2024, Renhe Pharmacy Co.,Ltd's revenue was 4.07 billion, a decrease of -19.02% compared to the previous year's 5.03 billion. Earnings were 481.91 million, a decrease of -15.05%.